INS and sarcopenia: Glucocorticoids are considered the main mediators of the poor long-term outcome of an adverse intrauterine environment, by stimulating hepatic gluconeogenesis, inhibiting insulin actions on skeletal muscle and potentiating insulin's actions on visceral adipose tissue, ultimately promoting visceral adiposity and sarcopenia leading to metabolic syndrome [15].